Potassium remains a huge deterrent for RAASi / Aldosterone-targeted therapy uptitration in #heartfailure & #CKD . A structured, evidence-based approach is the way forward to instill
confidence across the field! Thank you @AstraZeneca for the support & @HeartFailureDoc for leading
Conduction system pacing versus biventricular pacing after atrioventricular node ablation in heart failure with atrial fibrillation: the international randomized CONDUCT-AF trial π
#HeartFailure26#HFA_ESC@HFA_President